New hope for patients with untamable inflammatory disease
NCT ID NCT07151157
Summary
This study is testing if a drug called sirolimus can help control the severe inflammation and symptoms of Adult-Onset Still's Disease (AOSD) in patients who haven't improved with standard steroid treatments. It will involve just three patients with this rare, difficult-to-treat condition. Researchers will give patients sirolimus pills and closely monitor their symptoms and blood markers to see if the drug reduces disease activity and understand how it might work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT ONSET STILL'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruiiin Hospital Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.